FDA Nods da Vinci 5: ISRG Stock Climbs 3%
Quick Look Da Vinci 5 receives FDA 510(k) clearance less than two months post-submission. ISRG shares soared over 3% to $395.96 following the announcement. Introduction of surgeon controllers, advanced imaging, and force feedback technology. Following regulatory approvals, plans for a U.S. launch with a global rollout are on the horizon. Intuitive Surgical has received FDA …